Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Exercise  COVID-19 treatment studies for Exercise  C19 studies: Exercise  Exercise   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent: 
0 0.5 1 1.5 2+ Mortality 76% Improvement Relative Risk Hospitalization 51% c19early.com/ex Buckley et al. Exercise for COVID-19 Favors exercise Favors inactivity
Buckley, 1,286 patient exercise study: 76% lower mortality [p<0.0001] and 51% lower hospitalization [p<0.0001] https://c19p.org/buckley
copied to clipboard
Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19
Buckley et al., European Journal of Preventive Cardiology, doi:10.1093/eurjpc/zwaa135
5 Jul 2021    Source   PDF   Share   Tweet
PSM retrospective 643 COVID-19 patients with cardiovascular disease undergoing exercise rehabilitation within 3 months of diagnosis, showing significantly lower re-hospitalization and mortality with exercise rehabilitation.
risk of death, 75.8% lower, RR 0.24, p < 0.001, high activity levels 10 of 639 (1.6%), low activity levels 41 of 638 (6.4%), NNT 21, odds ratio converted to relative risk.
risk of hospitalization, 50.9% lower, RR 0.49, p < 0.001, high activity levels 97 of 643 (15.1%), low activity levels 198 of 643 (30.8%), NNT 6.4, odds ratio converted to relative risk.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Buckley et al., 5 Jul 2021, retrospective, USA, peer-reviewed, 7 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperExerciseAll
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit